These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 17130899)

  • 1. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).
    Pang T; Cardosa MJ; Guzman MG
    Immunol Cell Biol; 2007 Jan; 85(1):43-5. PubMed ID: 17130899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathology of dengue hemorrhagic fever.
    Leong AS; Wong KT; Leong TY; Tan PH; Wannakrairot P
    Semin Diagn Pathol; 2007 Nov; 24(4):227-36. PubMed ID: 18085063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large.
    Kurane I; Takasaki T
    Rev Med Virol; 2001; 11(5):301-11. PubMed ID: 11590668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune pathogenesis in dengue virus infection.
    Lin CF; Wan SW; Cheng HJ; Lei HY; Lin YS
    Viral Immunol; 2006; 19(2):127-32. PubMed ID: 16817755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.
    Chen HR; Lai YC; Yeh TM
    J Biomed Sci; 2018 Jul; 25(1):58. PubMed ID: 30037331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection.
    Chuang YC; Wang SY; Lin YS; Chen HR; Yeh TM
    J Biomed Sci; 2013 Jun; 20(1):42. PubMed ID: 23806052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control.
    Wang WH; Urbina AN; Chang MR; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    J Microbiol Immunol Infect; 2020 Dec; 53(6):963-978. PubMed ID: 32265181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Autoimmune Mechanism in Dengue Hemorrhagic Fever.
    Lardo S; Soesatyo MH; Juffrie J; Umniyati SR
    Acta Med Indones; 2018 Jan; 50(1):70-79. PubMed ID: 29686179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.
    Fink AL; Williams KL; Harris E; Alvine TD; Henderson T; Schiltz J; Nilles ML; Bradley DS
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005721. PubMed ID: 28686617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards understanding the pathogenesis of dengue hemorrhagic fever.
    Pang X; Zhang R; Cheng G
    Virol Sin; 2017 Feb; 32(1):16-22. PubMed ID: 27853992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of interacting immunological components in dengue pathogenesis.
    Nielsen DG
    Virol J; 2009 Nov; 6():211. PubMed ID: 19941667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells.
    Cabello-Gutiérrez C; Manjarrez-Zavala ME; Huerta-Zepeda A; Cime-Castillo J; Monroy-Martínez V; Correa BB; Ruiz-Ordaz BH
    Thromb Haemost; 2009 May; 101(5):916-28. PubMed ID: 19404546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue.
    Halstead SB
    Lancet; 2007 Nov; 370(9599):1644-52. PubMed ID: 17993365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of dengue fever in Karachi 2006: a clinical perspective.
    Riaz MM; Mumtaz K; Khan MS; Patel J; Tariq M; Hilal H; Siddiqui SA; Shezad F
    J Pak Med Assoc; 2009 Jun; 59(6):339-44. PubMed ID: 19534364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.
    Guzman MG; Alvarez M; Halstead SB
    Arch Virol; 2013 Jul; 158(7):1445-59. PubMed ID: 23471635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.
    Posadas-Mondragón A; Aguilar-Faisal JL; Chávez-Negrete A; Guillén-Salomón E; Alcántara-Farfán V; Luna-Rojas L; Ávila-Trejo AM; Del Carmen Pacheco-Yépez J
    Microbiol Immunol; 2017 Oct; 61(10):433-441. PubMed ID: 28881485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited.
    Marianneau P; Flamand M; Deubel V; Desprès P
    Clin Diagn Virol; 1998 Jul; 10(2-3):113-9. PubMed ID: 9741636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing pattern of dengue virus serotypes circulating during 2008-2012 and reappearance of dengue serotype 3 may cause outbreak in Kolkata, India.
    Saha K; Ghosh M; Firdaus R; Biswas A; Seth B; Bhattacharya D; Mukherjee K; Sadhukhan PC
    J Med Virol; 2016 Oct; 88(10):1697-702. PubMed ID: 26991505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S; Perng GC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.